CASI Site 02 — Boston, Massachusetts

CASI Site 02 is a clinical research site located in Boston, Massachusetts, United States 01003.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

CASI Site 02 has participated in 1 clinical trials.

Therapeutic areas: Advanced Adult Hepatocellular Carcinoma, Advanced Fibrolamellar Carcinoma.

Sponsors: CASI Pharmaceuticals, Inc..

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for CASI Site 02?

CASI Site 02 has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has CASI Site 02 conducted?

CASI Site 02 has 1 clinical trials on record. Their work covers Advanced Adult Hepatocellular Carcinoma, Advanced Fibrolamellar Carcinoma.

Is CASI Site 02 accredited by Crixeo Health?

CASI Site 02 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about CASI Site 02?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.